BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30932416)

  • 1. Time-dependent cytotoxicity of dichloroacetate and metformin against Lewis lung carcinoma.
    Kolesnik DL; Pyaskovskaya ON; Yakshibaeva YR; Solyanik GI
    Exp Oncol; 2019 Mar; 41(1):14-19. PubMed ID: 30932416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin enhances cytotoxic action of dichloroacetate against Lewis lung carcinoma cells in vitro.
    Kolesnik DL; Pyaskovskaya ON; Gorbach O; Solyanik GI
    Exp Oncol; 2020 Mar; 42(1):35-39. PubMed ID: 32231186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin enhances antitumor action of sodium dichloroacetate against glioma C6.
    Kolesnik DL; Pyaskovskaya ON; Yurchenko OV; Solyanik GI
    Exp Oncol; 2019 Jun; 41(2):123-129. PubMed ID: 31262158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment changes tumor cell sensitivity to action of energy metabolism modifiers.
    Pyaskovskaya ON; Kolesnik DL; Prokhorova IV; Burlaka АP; Gorbach OI; Solyanik GI
    Exp Oncol; 2020 Sep; 42(3):192-196. PubMed ID: 32996739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dichloroacetate on Lewis lung carcinoma growth and metastasis.
    Kolesnik DL; Pyaskovskaya ON; Boychuk IV; Dasyukevich OI; Melnikov OR; Tarasov AS; Solyanik GI
    Exp Oncol; 2015 Jun; 37(2):126-9. PubMed ID: 26112940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Deoxy-D-glucose enhances dichloroacetate antitumor action against Lewis lung carcinoma.
    Pyaskovskaya ON; Kolesnik DL; Fedorchuk AG; Prokhorova IV; Solyanik GI
    Exp Oncol; 2016 Sep; 38(3):176-80. PubMed ID: 27685525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of metformin, sodium dichloroacetate and their combination on the hematological and biochemical blood parameters of rats with gliomas C6.
    Prokhorova IV; Pyaskovskaya ON; Kolesnik DL; Solyanik GI
    Exp Oncol; 2018 Oct; 40(3):205-210. PubMed ID: 30284997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic activity of metformin in vitro does not correlate with its antitumor action in vivo.
    Pyaskovskaya ON; Kolesnik DL; Fedorchuk AG; Gorbik GV; Solyanik GI
    Exp Oncol; 2017 Dec; 39(4):264-268. PubMed ID: 29284782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia enhances antitumor activity of dichloroacetate.
    Kolesnik DL; Pyaskovskaya ON; Boichuk IV; Solyanik GI
    Exp Oncol; 2014 Dec; 36(4):231-5. PubMed ID: 25537215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
    Kumar A; Kant S; Singh SM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Cancer Cell Metabolism with Metformin, Dichloroacetate and Memantine in Glioblastoma (GBM).
    Albayrak G; Konac E; Dere UA; Emmez H
    Turk Neurosurg; 2021; 31(2):233-237. PubMed ID: 33372258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of sodium dichloroacetate against glioma C6 depends on administration schedule and dosage.
    Fedorchuk AG; Pyaskovskaya ON; Gorbik GV; Prokhorova IV; Kolesnik DL; Solyanik GI
    Exp Oncol; 2016 Jun; 38(2):80-3. PubMed ID: 27356574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EFFECT OF LACTATE DEHYDROGENASE INHIBITION BY OXAMATE ON LEWIS LUNG CARCINOMA CELLS WITH DIFFERENT METASTATIC POTENTIAL.
    Kolesnik DL; Prokhorova IV; Pyaskovskaya ON; Solyanik GI
    Exp Oncol; 2023 Oct; 45(2):242-251. PubMed ID: 37824767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells.
    Fedorchuk O; Susak Y; Rudyk M; Senchylo N; Khranovska N; Skachkova O; Skivka L
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):373-385. PubMed ID: 29290023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1.
    Kim TS; Lee M; Park M; Kim SY; Shim MS; Lee CY; Choi DH; Cho Y
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic-targeted Combination Therapy With Dichloroacetate and Metformin Suppresses Glioblastoma Cell Line Growth
    Korsakova L; Krasko JA; Stankevicius E
    In Vivo; 2021; 35(1):341-348. PubMed ID: 33402483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1.
    Voltan R; Rimondi E; Melloni E; Gilli P; Bertolasi V; Casciano F; Rigolin GM; Zauli G; Secchiero P
    Oncotarget; 2016 Apr; 7(14):18965-77. PubMed ID: 26959881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells.
    Ward NP; Poff AM; Koutnik AP; D'Agostino DP
    PLoS One; 2017; 12(6):e0180061. PubMed ID: 28644886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells.
    Choi YW; Lim IK
    Cancer Lett; 2014 May; 346(2):300-8. PubMed ID: 24480191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aconitine-containing agent enhances antitumor activity of dichloroacetate against Ehrlich carcinoma.
    Pyaskovskaya ON; Boychuk IV; Fedorchuk AG; Kolesnik DL; Dasyukevich OI; Solyanik GI
    Exp Oncol; 2015 Sep; 37(3):192-6. PubMed ID: 26422103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.